In breast cancer, the capacity of tumor-associated pDCs to produce type I IFN is substantially impaired, which in turn potentiates their capacity to promote the proliferation of tumor-associated forkhead box protein 3 (FOXP3)+ Treg cells (74). This evidence concerns the gene FOXP3 and neoplasm.